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Summary
Gingival fibromatosis is characterized by a slowly pro-
gressive benign enlargement of the oral gingival tissues.
The condition results in the teeth being partially or to-
tally engulfed by keratinized gingiva, causing aesthetic
and functional problems. Both genetic and pharmaco-
logically induced forms of gingival fibromatosis are
known. The most common genetic form, hereditary gin-
gival fibromatosis (HGF), is usually transmitted as an
autosomal dominant trait, although sporadic cases are
common and autosomal recessive inheritance has been
reported. The genetic basis of gingival fibromatosis is
unknown. We identified an extended family ( )n  32
segregating an autosomal dominant form of isolated gin-
gival fibromatosis. Using a genomewide search strategy,
we identified genetic linkage ( , ) forZ  5.05 v  .00max
the HGF phenotype to polymorphic markers in the ge-
netic region of chromosome 2p21 bounded by the loci
D2S1788 and D2S441. This is the first report of linkage
for isolated HGF, and the findings have implications for
identification of the underlying genetic basis of gingival
fibromatosis.
Introduction
Hereditary gingival fibromatosis (HGF) is characterized
by a slowly progressive, benign enlargement of the ker-
atinized oral gingival tissues. Gingival tissues surround-
ing both the maxillary and the mandibular dentitionmay
be affected. As a result, the teeth become buried, to var-
ying degrees, beneath the redundant hyperplastic tissues,
which results in both aesthetic and functional problems
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(Laband et al. 1964; Cuestas-Carnero and Bornancini
1988). Although HGF most commonly presents as an
isolated clinical finding, it is also known to occur as part
of a number of syndromes (Gorlin et al. 1976). The
relationship between isolated hereditary and syndromic
presentations of gingival fibromatosis is unclear.
In addition to Mendelian and syndromic forms, gin-
gival fibromatosis is also known to be induced by certain
classes of pharmacologics, including phenytoin, calcium-
channel blockers, and cyclosporin (Hassell and Hefti
1991). These drugs are used in the treatment of seizure
disorders (phenytoin), hypertension and angina (cal-
cium-channel blockers), and organ transplants and au-
toimmune diseases (cyclosporin). Although these drugs
differ in their primary target tissues, they share similar-
ities with respect to their pharmacological mechanisms
of action at the cellular level, and they may act similarly
on a common secondary target tissue, such as gingival
connective tissue (Dongari et al. 1993). The reported
incidences of significant gingival fibromatosis occurring
with these drugs are 13%–15% (phenytoin), 10%–15%
(calcium-channel blockers; e.g., nifedipine), 30% (cy-
closporin), and 40% (combined cyclosporin and nife-
dipine, used to treat transplant patients). This differ-
ential potential to develop gingival fibromatosis after
exposure to these pharmacologics may have a genetic
basis (Pernu et al. 1994) that determines whether an
individual is a “responder” (develops gingival over-
growth) or not. Genetic polymorphisms may account
for the differential response to pharmacotopic agents
associated with drug-induced gingival fibromatosis. Pol-
ymorphisms have been identified, at both genetic and
phenotypic levels, in a variety of xenobioticmetabolizing
enzymes that predispose certain individuals to physio-
logic effects of particular pharmacologic agents (Daly et
al. 1993). Although genetic factors appear to play a sig-
nificant role in many types of gingival fibromatosis, the
underlying genes responsible for these disorders are
unknown.
Identification of the genetic basis of HGFmay provide
a beginning to understand genetic and pharmacologi-
cally induced forms of gingival fibromatosis. The pur-
pose of the present investigation was to identify genetic
linkage, as a first step toward identification of the gene
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Figure 1 Pedigree of family segregating the HGF phenotype. Genetic haplotypes are presented for all individuals genotyped. Boxes surround
alleles inherited from individual I-1.
defect(s) responsible for HGF. We have identified an ex-
tended family segregating a highly penetrant, autosomal
dominant form of isolated HGF ( , 12 affected).n  32
Using a genomewide search strategy, we obtained con-
clusive evidence for linkage of an HGF locus to markers
on chromosome 2p21. This is the first report of linkage
for isolated HGF, and it has implications for identifi-
cation of the underlying genetic basis.
Material and Methods
Ascertainment of Family Members
A three-generation Brazilian family segregating for
HGF was identified when the proband presented to the
University of Taubate´ dental clinic, seeking treatment
for her enlarged gingiva. Figure 1 shows the family ped-
igree. Informed consent was provided by all study par-
ticipants prior to their inclusion in the study. All indi-
viduals received an oral/ dental examination and, on the
basis of presence or absence of gingival enlargement,
were classified as either affected or unaffected. To be
classified as affected, an individual had to have keratin-
ized gingival tissues covering at least one-third of the
clinical crowns of a minimum of five teeth. All individ-
uals were asked about exposure to prescription and non-
prescription medications in general and about exposure
to specific pharmacologics associated with gingival over-
growth, including phenytoin, cyclosporin, and calcium-
channel blockers.
DNA-Marker Analysis
Peripheral venous blood (7.5 ml) was obtained by
standard venipuncture. Genomic DNA was extracted by
means of the QIAamp blood kit (QIAMP). We per-
formed an initial genomewide scan by use of the Weber
version 6A low-density markers (Research Genetics), us-
ing standard techniques for PCR amplification with ra-
dioactively labeled g-[32P] primers, according to the
manufacturer’s protocol, with a PCR 9600 thermocycler
(Applied Biosystems) (Weissenbach et al. 1992). After
identification of a linkage relationship, individuals were
genotyped for a high-density array of DNAmarkers that
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Table 1
LOD Scores at Standard Values of v and at the Maximum Likelihood Estimate (Zmax) of vmax, Equal Values of v in Both Sexes, for Markers
from Chromosome 2p
MARKERa
LOCATION
(CM)b nc HETEROZYGOSITY
LOD SCORE AT v
Zmax vmax.00 .01 .05 .1 .2 .3 .4
D2S392 57 4 .68  2.94 .39 .47 .96 .85 .43 .97 .22
D2S405 58 5 .80  5.09 2.40 1.33 -.42 .05 .06 .01 .41
D2S1788 64 5 .89  2.97 3.37 3.28 2.72 1.92 .94 3.37 .05
D2S1346 68 5 .93 5.05 4.97 4.65 4.23 3.32 2.29 1.11 5.05 .00
D2S1348 68 5 .93 5.05 4.97 4.65 4.23 3.32 2.29 1.11 5.05 .00
D2S119 75 6 .80 5.05 4.97 4.65 4.23 3.32 2.29 1.11 5.05 .00
D2S1352 82 3 .75 5.01 4.94 4.62 4.20 3.30 2.27 1.11 5.01 .00
D2S2739 )d 6 .95 5.04 4.96 4.64 4.23 3.31 2.28 1.11 5.04 .00
D2S406 91 3 .82 5.02 4.94 4.62 4.20 3.30 2.27 1.11 5.03 .00
D2S1337 91 3 .65 5.02 4.94 4.62 4.20 3.30 2.27 1.11 5.02 .00
D2S441 101 5 .75  3.04 3.43 3.33 2.77 1.96 .96 3.44 .56
D2S443 103 6 .81  2.97 3.37 3.28 2.72 1.92 .94 3.38 .57
D2S1394 108 3 .81  3.04 3.43 3.33 2.77 1.96 .96 3.44 .56
a Marker loci showing no recombination with the HGF phenotype are underlined.
b From telomeric end of 2p.
c Total number of different alleles identified in the pedigree set.
d Most likely location between D2S1346 and D2S441.
spanned the genetic interval from D2S392 to D2S1394
(table 1). These markers were selected from the Coop-
erative Human Linkage Center Chromosome 2 version
v8 c7 integrated marker map (http://www.chlc.org) and
the Whitehead Institute STS-based Map of the Human
Genome (http://www-genome.wi.mit.edu). After PCR
amplification, individual samples were separated on a
6% PAGE 7M urea gel (30 W, 1,500 V). An M13 se-
quencing ladder (Sequenase kit, USB) was loaded onto
each gel, to permit sizing of individual alleles. After elec-
trophoresis, gels were wrapped in cellophane, exposed
in a phosphorimaging cassette for 15 min, and scanned
(Molecular Dynamics). Alleles were scored, and geno-
type data were entered into the pedigree file of the LINK-
AGE computer package (Lathrop and Lalouel 1984).
Linkage Analysis
Autosomal dominant inheritance with complete pen-
etrance was assumed, and LOD scores were generated.
The affected allele frequency was taken as .0001.Marker
allele frequencies were assumed to be uniformly distrib-
uted. Calculations using marker allele frequencies re-
ported in available databases were also performed, but
these changes had minimal effects on the LOD scores
generated. The number of alleles at each marker locus
is shown in table 1. Two-point linkage analysis was per-
formed by use of the MLINK program version 5.1 from
the LINKAGE computer program (Lathrop and Lalouel
1984). At any given locus, results for the pedigree were
used to generate a final LOD score for each marker
tested. Precise values for maximum LOD scores (Zmax)
were calculated with the ILINK program from the same
computer package. Multipoint analyses were performed
by FASTLINK (Cottingham et al. 1993; Schaffer et al.
1994). A multipoint map was constructed from several
runs with overlapping sets of marker loci. Haplotype
analysis was used for error elimination during the link-
age scan and for determination of the critical linkage
segment. Haplotype construction was performed using
the CRIMAP program with the CHROMPIC option
(Lander and Green 1987).
Cytogenetic Studies
To evaluate the possibility of chromosomal changes,
cytogenetic studies were performed on 72-h phytohem-
agglutinin-stimulated peripheral blood cultures from
two affected individuals (III-4 and III-7) and from one
unaffected individual (III-6). Routine cultures were es-
tablished in RPMI 1640 by means of standard labora-
tory techniques. Chromosome preparations were ob-
tained by use of a modified ethidium bromide procedure
(Ikeuchi 1984). Standard International System for Cy-
togenetic Nomenclature was followed, with high-reso-
lution (650 band level) analysis performed on 30 trypsin-
Giemsa–banded metaphases.
Results
Clinical Findings
Of the 32 family members identified, 29 received an
oral examination (fig. 1). Twelve of these individuals,
with enlarged keratinized gingival tissues covering at
least one-third of the clinical crown of five or more teeth,
were classified as affected. In affected individuals, all
teeth were generally affected, although the severity of
Hart et al.: Hereditary Gingival Fibromatosis 879
Figure 2 A, Clinical photograph (individual III-4) showing gingival fibromatosis. B, Periapical radiograph (individual III-4) showing
normal level of alveolar bone. C, Histological section showing extension of epithelial rete pegs into underlying corneum (hematoxylin and eosin
stain, original magnification #100).
gingival enlargement varied considerably, from gingival
enlargement covering one-third of clinical crowns of
teeth to enlargement fully engulfing the crowns (fig. 2A).
Periapical radiographs showed that there was no in-
crease in alveolar bone surrounding involved teeth, con-
sistent with the clinical impression of increased gingival
soft tissues (fig. 2B). The proband (individual III-4) was
treated surgically to remove the excess gingival tissues,
and a recurrence of gingival overgrowth occurred. His-
tological evaluations of surgical resection tissue were
consistent with gingival fibromatosis, and no evidence
of an osseous component was seen (fig. 2C). No family
members reported taking any class of pharmocologics
(phenytoin, calcium-channel blockers, and cyclosporin)
implicated in drug-induced gingival overgrowth. All
family members were systemically healthy and were of
normal intelligence. No family members reported a pos-
itive history of hearing loss, epilepsy, or hypertrichosis,
findings associated with syndromic forms of gingival fi-
bromatosis. Gingival fibromatosis was present in all gen-
erations, male-to-male transmission of the conditionwas
observed, and there were approximately equal propor-
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Figure 3 Multipoint LOD-score calculations between the HGF phenotype and markers D2S392, D2S405, D2S1788, D2S1346, D2S1348,
D2S119, D2S1352, D2S1337, D2S406, D2S441, and D2S1394. The multipoint LOD score is represented on the x axis. The positions of the
DNA marker loci tested are located on the y axis, together with the genetic location coordinate (in centimorgans) according to the Ge´ne´thon
map; the zero coordinate is at the short-arm telomere (Gyapay et al. 1994). Marker D2S2739 has not been included in the multipoint analysis
because its precise genetic location was not known.
tions of affected males (.55) and females (.54). The pa-
ternal grandfather was deceased, but his family dentist
reported that the grandfather had been affected by gin-
gival fibromatosis. Segregation of gingival fibromatosis
in this family was consistent with autosomal dominant
transmission with high penetrance. Clinical findings for
individuals classified as affected were consistent with iso-
lated HGF (MIM 135300).
Two-Point Linkage Analysis
Using a genomewide search strategy, we genotyped all
individuals for a low-density STRP locus–screening
panel (Weber Version 6A). Two-point LOD scores sup-
portive of linkage were obtained for only two markers,
D2S1788 ( , recombination fraction (v) ofZ  3.37max
.05) and D2S441 ( , ). All individualsZ  3.43 v  .05max
were then genotyped with markers from a high-density
map of additional closely spaced markers that spanned
the genetic interval between D2S392 and D2S1394.
Two-point LOD scores for markers spanning the can-
didate interval are summarized in table 1.
A Zmax of 5.05 was obtained for D2S1346, D2S1348,
and D2S119 at . Results of the linkage analysisv  .00
for the other genome-scan markers (outside of the chro-
mosome 2p region) were not supportive of linkage with
HGF in this family. Although the absolute value of two-
point LOD scores calculated for HGF with these genetic
markers varied, ∼70% of the markers were able to sig-
nificantly reject the linkage hypothesis in the vicinity of
the marker tested (i.e., two-point LOD scores !2.0 for
values of v ranging from .00 to .10). For those markers
that did not reject linkage at the level of statistical sig-
nificance, several were uninformative or only partially
informative, none were supportive of linkage, and no
LOD scores 11.0 were obtained for any marker tested,
at any specified value of v. Because of the report of
gingival fibromatosis associated with recombinant 8 syn-
drome, we also tested for a linkage relationship between
HGF and 18 genetic markers spanning chromosome 8.
Results of two-point LOD score calculations provided
statistical evidence against linkage for HGF with the
genetic markers tested (LOD score X2.0).
Haplotype and Multipoint Linkage Analysis
To define the smallest interval containing the HGF
locus, we analyzed individuals for recombination events,
by haplotype reconstruction. The cosegregating segment
in which recombination was not detected was flanked
by the markers D2S1788 and D2S441. Multipoint link-
age analysis using 11 STRP markers yielded a maximum
multipoint LOD score of 5.11 at D2S1346 and
D2S1348. Using a criterion of LOD 1.0 to determine
the 95% confidence interval (Conneally et al. 1985), we
determined that the HGF locus lies between the genetic
interval flanked by D2S441 and D2S1788 (fig. 3).
Possible Suppression of Meiotic Recombination in the
HGF 2p21 Candidate Interval
The genetic interval in the candidate region is ∼37
cM. The amount of recombination observed in this in-
terval appears to be less than expected. We can evaluate
this by calculating the probability of observing no re-
combinants in the interval for sex-average genetic maps.
This is calculated by use of the equation ,nP  (1 v)
where v is the distance in which no recombination is
observed and n is the number of equivalent meioses,
calculated with the EQUIV program from the Linkage
Utility Package (J. Ott, personal communication).
For the sex-averaged map, the distance betweenmark-
ers unseparated by recombination is 37 cM, correspond-
ing to . The calculated P value is therefore .002,v  .31
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which suggests that absence of recombination is not
merely due to chance. The male and female genetic map
distances in this region of chromosome 2p21 are not
equivalent. The male genetic map distance from
D2S1788 to D2S441 is ∼18.9 cM, and the female genetic
map distance is 58.9 cM (Chromosome 2 Version 4.0
Recmin extended Weber Version 6 screening set sex-
specific maps [http://www.chlc.org]). Even whenwe con-
sider the differing lengths of the male and female genetic
maps, we can calculate the probability of observing no
recombinants, using the equation nmP  (1 v ) (1mf m
, where vm is the male distance, vf is the female dis-
nfv )f
tance, nm is the number of male meioses, and nf is the
number of female meioses. Using this equation and the
appropriate distances (male genetic distance [18.9 cM]
corresponds to , female genetic distance [58.9v  .18
cM] corresponds to ) and meioses, we deter-v  .41
mined that the probability of observing no recombinants
is .003, consistent with the sex-average calculation. One
possible explanation for this phenomenon is a chro-
mosomal rearrangement that reduces the efficiency of
chromatid pairing in meiosis, resulting in a decrease in
meiotic recombination.
Cytogenetics
Cytogenetic analysis on stimulated peripheral blood
revealed normal karyotypes (46,XX) in all cells of the
three individuals examined (III-4, III-6, and III-7). Ex-
tended examination of the 2p21 chromosomal region
did not identify any chromosomal rearrangements that
could account for the suppression of recombination ob-
served across the interval of interest.
Discussion
Results of the present study have identified a major
gene locus for HGF on chromosome 2p21. Results of
the genomewide scan did not demonstrate support for
linkage at any other site, and no LOD score 11.0 was
found outside the chromosome 2p21 region. Because of
the association of gingival fibromatosis with recombi-
nant chromosome 8 syndrome, we genotyped 18 STRP
markers spanning chromosome 8. Results of linkage
analysis with these markers excluded an HGF locus on
chromosome 8 (LOD scores !2.0). Although the re-
sults for this family are quite conclusive, it will be nec-
essary to evaluate this linkage relationship in additional
families to determine whether this region represents a
common HGF linkage. The genetic region segregating
with the HGF phenotype is ∼37 cM. The amount of
genetic recombination observed across this region is less
than expected ( ). The reason for the apparentP  .003
suppression of meiotic recombination in the HGF can-
didate interval observed in this family is unknown. Re-
sults of high-resolution chromosomal banding studies
performed on two affected and one unaffected family
members did not indicate the presence of any cytogenetic
rearrangement that would account for meiotic suppres-
sion. It is difficult to imagine how any factor that sup-
presses meiotic recombination could be causal for gin-
gival fibromatosis. However, genetic linkage studies of
other families demonstrate meiotic recombination across
the interval flanked by D2S1788 and D2S441, indicating
that the suppression of recombination in this interval
may be unique to this family. Whether this is related to
HGF in this family is unknown.
In the current family, HGF appears to segregate as a
highly penetrant autosomal dominant trait. Inheritance
patterns for isolated gingival fibromatosis are most con-
sistent with autosomal dominant inheritance with in-
complete penetrance and variable clinical expression
(Jorgenson and Cocker 1974; Raeste et al. 1978), but
autosomal recessive transmission has also been reported,
and the condition is often reported to be sporadic.
Whether the high frequency of sporadic cases reflects a
high new-mutation rate, incomplete penetrance, or var-
iable clinical expression and underdiagnosis of mild
cases is unclear. Unfortunately, there are no biologic or
molecular markers to aid in the diagnosis of gingival
fibromatosis, and, as a result, diagnosis of affected in-
dividuals can be problematic, particularly in cases of
mild expression. The availability of genetically linked
DNA markers will, for the first time, provide the means
for studying HGF.
Histological evaluation of HGF tissues show a fairly
nonspecific hyperplasia of fibrous tissue of the corneum.
The affected gingival tissues are composed mainly of
dense connective tissue that is rich in collagen fibrils but
contains only a few fibroblasts. The overlying epithelium
is typically normal but may be slightly hyperplastic with
rete pegs extending deeply into the corneum (fig. 2C).
Although osseous involvement has been reported in
HGF, it is apparently uncommon (Fritz 1970). Therewas
no evidence of an osseous component of gingival en-
largement in the present family. Osseous involvement
was assessed by histological evaluation of surgical re-
section tissues and by assessment of standard periapical
radiographs (fig. 2B). Gingival fibromatosis typically ap-
pears to consist of increased soft tissue, primarily epi-
thelium and corneum. Although a number of potential
biological mechanisms have been proposed for HGF, the
genetic basis for gingival fibromatosis is currently un-
known. Fibromatosis tissues have been reported to con-
tain fibroblasts that have low growth activity but are
active in the production of greater amounts of collagen
and other extracellular substances (e.g., glycosaminogly-
cans) compared with normal fibroblasts (Shirasuna et al.
1989). Preliminary studies of gingival tissues from the
proband of the family studied in the present report sug-
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gest that altered collagen cross-linking may be etiolog-
ically important. For assessment of collagen cross-link-
ing, gingival resection tissues were pulverized in liquid
nitrogen and reduced with NaB3H4, hydrolyzed with 6N
HCl, and subjected to amino acid and cross-link anal-
yses. Results revealed a 30% increase in dehydro-di-
hydroxlysinonorleucine cross-linking in fibromatous
gingiva compared with control gingiva (Pallos et al.
1997). Increased collagen cross-linking may increase re-
sistance to degradation and may contribute to collagen
accumulation. These preliminary results suggest that al-
tered posttranslational modifications of collagen may be
etiologically important in HGF.
In addition to Mendelian autosomal transmission,
chromosomal anomalies have been identified in syn-
dromic forms of gingival fibromatosis (Gorlin et al.
1976). The most common syndromic forms of gingival
fibromatosis occur with hypertrichosis, epilepsy, and
mental retardation. Other syndromic forms of gingival
fibromatosis include sensorineural hearing loss; juvenile
hyaline fibromatosis; corneal dystrophy (Rutherford
syndrome); ear, nose, bone, and nail defects (Laband
syndrome); microphthalmia, athetosis, and hypopig-
mentation (Cross syndrome); cherubism, hypertrichosis,
mental and somatic retardation, and epilepsy (Ramon
syndrome); and growth-hormone deficiency (Gorlin et
al. 1976). Recently, Fryns (1996) reported a partial du-
plication of chromosome 2p13-p21 in an individual with
gingival fibromatosis and mental retardation. The region
of chromosome 2p13-p21 duplication reported by Fryns
contains the HGF candidate region identified in the pres-
ent study. These observations raise the possibility that a
common gene locus on chromosome 2p may be involved
in at least some isolatedMendelian and syndromic forms
of HGF. It is possible that isolated gingival fibromatosis
may result from a single gene mutation, whereas syn-
dromic forms may result from alterations of multiple
genes and/or from a gene-dosage affect. The generality
of the chromosome 2p21 locus for Mendelian or syn-
dromic forms of gingival fibromatosis is unknown. Syn-
dromic gingival fibromatosis with sensorineural deafness
has been reported (OMIM 135550), and it is possibly
significant that a gene for deafness (DFNB9) has recently
been identified in the 2p22 region (Hartsfield et al. 1985;
Chaib et al. 1996). Although it is unknown whether
Mendelian forms of gingival fibromatosis are genetically
heterogeneous, the association of gingival fibromatosis
with recombinant chromosome 8 syndrome suggests
that there are genetically distinct forms of syndromic
gingival fibromatosis (Sujansky et al. 1993).
In addition to Mendelian and syndromic forms of gin-
gival fibromatosis, pharmacologically associated forms
are also known. Gingival enlargement may occur sec-
ondary to exposure to certain classes of pharmacologics,
including phenytoin, cyclosporin, and calcium-channel
blockers. Whether these conditions share any etiologic
commonality is not known. Not everyone exposed to
these pharmacologics develops gingival fibromatosis,
and it is possible that allelomorphic polymorphisms at
one or more different genetic loci may account for this
differential response to one or more of these pharma-
cologic agents. A common mechanism of action of the
pharmacological agents associated with gingival fibro-
matosis involves cellular regulation of calcium. The ge-
netic interval containing the HGF locus identified in the
present study includes at least two genes important in
calcium regulation, calmodulin (CALM2) and sodium-
calcium exchanger 1 (NCX1). Calmodulin is the arche-
type of the family of calcium-modulated proteins of
which 120 members have been identified. Calmodulin
functions in growth and the cell cycle as well as in signal
transduction and in synthesis and release of neurotrans-
mitters. Calmodulin is the delta subunit of phosphoryl-
ase kinase, which has three other types of subunits. Al-
though only one form of calmodulin has been found in
humans, three distinct human cDNAs have been isolated
that encode the identical polypeptide. The existence of
three expressible genes for calmodulin may indicate that
one is a housekeeping gene and that the additional copies
are differentially regulated to modulate calmodulin func-
tion (OMIM 114180). The amino acid sequence of the
sodium-calcium–exchanger gene NCX1 does not resem-
ble any previously described protein. In the heart, the
exchanger may play a key role in digitalis action. The
exchanger is the dominant mechanism in returning the
cardiac myocyte to its resting state after excitation. The
NCX1 gene is located just inside the chromosome 2p21
interval of interest, betweenD2S1348 andD2S119. Both
NCX1 and CALM2 lie within the chromosome 2p21
interval that cosegregates with HGF and, as such, must
be considered for a possible role in HGF. However, mu-
tational studies have not yet been performed, and the
roles of NXC1 and CALM2, if any, in gingival fibro-
matosis are unknown. It is possible that naturally oc-
curring polymorphisms in these genes are important in
pharmacologically induced forms of gingival over-
growth, whereas mutations in one of these genes may
be important in HGF.
The biologic basis for gingival fibromatosis is un-
known, but this first report of linkage for isolated HGF
may provide the basis for strategies to identify the re-
sponsible gene. Identification of linkage for isolated
HGF will also permit evaluation of the generality of
HGF linkage to chromosome 2p, thereby testing support
for allelic versus nonallelic heterogeneity for isolated gin-
gival fibromatosis. Elucidation of the gene mutation re-
sponsible for HGF will permit investigation of possible
common etiologic factors between different genetic and
pharmacologically induced conditions manifesting gin-
gival fibromatosis.
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